U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that lifted Galapagos’s shares 18 percent to an all-time high on Monday.
Source:: Reuters – Business News
